Electronic Nicotine Delivery Systems (ENDS): Implications for the Clinician

Area of Science:

• Public Health
• Toxicology
• Clinical Medicine

Background:

• Tobacco cigarettes pose significant health risks, prompting the development of Electronic Nicotine Delivery Systems (ENDS) as potentially safer alternatives.
• ENDS, encompassing e-cigarettes and heated tobacco products, are user-friendly, portable devices that heat liquids to produce aerosols.
• The increasing prevalence of ENDS necessitates an understanding of their toxicological, clinical, and epidemiological implications.

Purpose of the Study:

• To evaluate the role of ENDS as a smoking cessation aid.
• To review the toxicological, clinical, and epidemiological aspects of ENDS use.
• To provide guidance for physicians regarding ENDS in smoking cessation management.

Main Methods:

• Narrative review of existing literature.
• Analysis of randomized controlled trials (RCTs) on e-cigarettes for smoking cessation.
• Examination of epidemiological data on ENDS prevalence and quit rates.

Main Results:

• RCTs indicate that e-cigarettes can aid in achieving cigarette smoking cessation.
• Real-world data show no clear association between e-cigarette use prevalence and overall smoking quit rates.
• Despite lacking FDA/EMA approval for cessation, ENDS are widely used as a smoking cessation support device.

Conclusions:

• While e-cigarettes demonstrate potential for smoking cessation in controlled settings, their effectiveness in real-world scenarios requires further investigation.
• Physicians play a crucial role in discussing ENDS use, advising on cessation strategies, and guiding patients on discontinuing ENDS use.
• Clear guidance is needed for healthcare providers to manage ENDS as a cessation tool and address long-term usage concerns.